We are live on ! Find out more
KBIO

KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO

Delisted

KBIO was delisted on the 16th of December, 2015.

Back to rankings

39 hedge funds and large institutions have $69.9M invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2013 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
1
Primecap Management
California
$20.8M +$20.9M +460,209 New
MAM
2
MPM Asset Management
Massachusetts
$14.9M +$14.9M +329,116 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$12.2M +$13.1M +288,479 New
LBH
4
Lehman Brothers Holdings
New York
$6.04M +$6.05M +133,382 New
BIT
5
BlackRock Institutional Trust
California
$2.67M +$2.67M +58,963 New
WSA
6
Wall Street Associates
California
$2.34M +$2.34M +51,625 New
Principal Financial Group
7
Principal Financial Group
Iowa
$1.7M +$1.7M +37,500 New
Franklin Resources
8
Franklin Resources
California
$1.66M +$1.66M +36,597 New
AWMDMG
9
Austin W. Marxe & David M. Greenhouse
New York
$1.5M +$1.5M +33,139 New
BFA
10
BlackRock Fund Advisors
California
$1.27M +$1.27M +28,045 New
Northern Trust
11
Northern Trust
Illinois
$592K +$593K +13,089 New
UBS AM
12
UBS AM
Illinois
$548K +$549K +12,113 New
State Street
13
State Street
Massachusetts
$538K +$539K +11,877 New
DCM
14
Driehaus Capital Management
Illinois
$530K +$530K +11,695 New
DCM
15
DAFNA Capital Management
California
$452K +$452K +9,979 New
UOC
16
UBS O'Connor
Illinois
$393K +$393K +8,672 New
Vanguard Group
17
Vanguard Group
Pennsylvania
$342K +$342K +7,544 New
Morgan Stanley
18
Morgan Stanley
New York
$303K +$303K +6,680 New
William Blair & Company
19
William Blair & Company
Illinois
$135K +$136K +3,000 New
TCIM
20
TIAA CREF Investment Management
New York
$132K +$132K +2,911 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$125K +$125K +2,757 New
BA
22
BlackRock Advisors
Delaware
$124K +$124K +2,728 New
BIM
23
BlackRock Investment Management
Delaware
$124K +$124K +2,734 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$86K +$86.4K +1,905 New
Charles Schwab
25
Charles Schwab
California
$66K +$70.3K +1,550 New
1
2

KBIO Hedge Fund Activity: Q2 2013 in Review

39 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q2 2013, worth a combined $69.9M.

Buyers outnumbered sellers: 39 funds opened new KBIO positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

  • 39 institutional investors held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $69.9M of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q2 2013.
  • 39 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q2 2013 and 0 closed out, a net change of +39 holders.

Based on aggregated 13F filings for Q2 2013.